Clinical Trial Update: A Study of Oxytocin PK After IV Administration in Healthy Subjects and Advanced Knee Arthritis Subjects [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating oxytocin pharmacokinetics after IV administration in healthy subjects and knee osteoarthritis patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Osteoarthritis, Knee | Phase 2 | Status: WITHDRAWN